Anoro Ellipta (umeclidinium/vilanterol) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). Anoro Ellipta can interact with ...

Most popular cars under 22 Lakh are Mahindra XUV700, Hyundai Creta, Tata Nexon, Tata Curvv, Maruti Suzuki Fronx, Toyota Urban Cruiser Hyryder, Maruti Suzuki Brezza and Mahindra Scorpio N.

Flyme OS is alive and Meizu is back! The maker returns to MWC with three global smartphones - Note 22, mblu 22, mblu 22 Pro. These three run on Android 15 with Flyme skin. Meizu Note 22 is an ...

SPRINGFIELD, Mo. (KY3) - A woman is recovering after her car went off Highway 65 and hit a guardrail Saturday morning. According to Springfield Police, the crash happened around 10 a.m. in the ...

Those are not hefty sums. The average monthly retirement benefit, as of January, was recently $1,979 -- roughly $23,750 annually. Here are some silver linings, though: For starters, Social ...

Rukobia sales rose 46% in the quarter. Sales of new long-acting medicines, Cabenuva and Apretude, rose 43% and 65%, respectively in the quarter. The growth of these products comes from strong ...

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

Its biggest competitor is GSK, which also has a new dual bronchodilator Anoro Ellipta. Results from GSK's combination have underwhelmed until now, and failed to show superiority to the older ...

What’s the latest on QDEL? Can AVRs damage your picture quality? And are 55- and 65-inch TV sizes being phased out? Leon writes: Given technological developments, why don’t manufacturers try ...

The average monthly Social Security benefit for retired workers in December 2024 was $1,342 at age 62, $1,611 at age 65, and $2,148 at age 70. Retired workers born in 1960 or later will increase ...

Rukobia sales rose 46% in the quarter. Sales of new long-acting medicines, Cabenuva and Apretude, rose 43% and 65%, respectively in the quarter. The growth of these products comes from strong patient ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as ...